Op.Dr.Gökhan ATEŞ — Antalya Obezite CerrahisiOp.Dr.Gökhan ATEŞ
Decision Making

BMI 30–35 and Bariatric Surgery: When Is It Considered?

Traditionally, bariatric surgery was considered at BMI 35 and above. However, updated ASMBS/IFSO 2022 joint guidelines allow evaluation of selected patients with BMI 30–34.9 who have metabolic disease.

Updated Criteria

The ASMBS/IFSO 2022 joint statement indicates surgery at BMI 35 and above regardless of comorbidities. At BMI 30–34.9, surgery may be considered in patients with uncontrolled type 2 diabetes or severe metabolic disease.

Factors Considered

Duration and severity of type 2 diabetes

Presence of hypertension, dyslipidaemia

Non-alcoholic fatty liver disease / NASH

Severe obstructive sleep apnoea

Quality of life impairment from joint pain

Response to prior treatment attempts

Decision Process

BMI alone is insufficient. Waist circumference, body composition, comorbidity control, patient motivation, and prior therapy responses are evaluated together.

Important Caveat

Surgery at lower BMI is not a cosmetic procedure. Use outside recognised indications does not meet regulatory standards. The decision is individual and follows multidisciplinary evaluation.

References

  • Eisenberg D et al., 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery
  • ADA Standards of Care in Diabetes — Obesity and Weight Management
Medical notice: The information on this page is for general patient education only and does not replace medical diagnosis, treatment, or a surgical decision. The appropriate method for you can only be determined after a physician's assessment and necessary tests.

Last updated: 28.06.2026 · Medical content: Op.Dr.Gökhan ATEŞ

Request a Preliminary Assessment All articles